Kingdon Capital Management, L.L.C. Ptc Therapeutics, Inc. Transaction History

Kingdon Capital Management, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$45.41 - $57.07 $11.4 Million - $14.4 Million	-251,734 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$32.37 - $59.36 $1.55 Million - $2.85 Million	48,023 Added 23.57%	251,734 $11.2 Million
Q4 2019 Feb 14, 2020	BUY	$32.22 - $50.07 $663,474 - $1.03 Million	20,592 Added 11.25%	203,711 $9.78 Million
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $1.55 Million - $2.21 Million	45,900 Added 33.45%	183,119 $6.19 Million
Q2 2019 Aug 14, 2019	BUY	$35.42 - $45.0 $4.86 Million - $6.17 Million	137,219 New	137,219 $6.18 Million

223

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.03B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.